Literature DB >> 11429549

Activation and accumulation of B cells in TACI-deficient mice.

M Yan1, H Wang, B Chan, M Roose-Girma, S Erickson, T Baker, D Tumas, I S Grewal, V M Dixit.   

Abstract

The tumor necrosis factor (TNF)-related ligand B lymphocyte stimulator (BLyS) binds two TNF receptor family members, transmembrane activator and calcium-modulating and cyclophilin ligand interactor (TACI) and B cell maturation molecule (BCMA). Mice that are transgenic for BLyS show B cell accumulation, activation and autoimmune lupus-like nephritis. The existence of at least two distinct BLyS receptors raises the question of the relative contribution of each to B cell functions. We therefore generated mice that were deficient in TACI. TACI-/- mice showed increased B cell accumulation and marked splenomegaly. Isolated TACI-/- B cells hyperproliferated and produced increased amounts of immunoglobulins in vitro. In vivo antigen challenge resulted in enhanced antigen-specific antibody production. Thus, TACI may play an unexpected inhibitory role in B cell activation that helps maintain immunological homeostasis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11429549     DOI: 10.1038/89790

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  111 in total

1.  Impaired IgA class switching in APRIL-deficient mice.

Authors:  Emanuela Castigli; Sumi Scott; Fatma Dedeoglu; Paul Bryce; Haifa Jabara; Atul K Bhan; Emiko Mizoguchi; Raif S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-26       Impact factor: 11.205

2.  Cutting edge: regulation of TLR4-driven B cell proliferation by RP105 is not B cell autonomous.

Authors:  Jessica L Allen; Leah M Flick; Senad Divanovic; Shaun W Jackson; Richard Bram; David J Rawlings; Fred D Finkelman; Christopher L Karp
Journal:  J Immunol       Date:  2012-01-30       Impact factor: 5.422

Review 3.  Rheumatologic and autoimmune manifestations of primary immunodeficiency disorders.

Authors:  Ramona Goyal; Ariel C Bulua; Nikolay P Nikolov; Pamela L Schwartzberg; Richard M Siegel
Journal:  Curr Opin Rheumatol       Date:  2009-01       Impact factor: 5.006

4.  Unexpected development of autoimmunity in BAFF-R-mutant MRL-lpr mice.

Authors:  Zhong L Ju; Gui Y Shi; Jin X Zuo; Jing W Zhang
Journal:  Immunology       Date:  2006-10-31       Impact factor: 7.397

Review 5.  B lymphocyte stimulator protein levels in systemic lupus erythematosus and other diseases.

Authors:  William Stohl
Journal:  Curr Rheumatol Rep       Date:  2002-08       Impact factor: 4.592

6.  Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes.

Authors:  Li Zhang; Lin Radigan; Ulrich Salzer; Timothy W Behrens; Bodo Grimbacher; George Diaz; James Bussel; Charlotte Cunningham-Rundles
Journal:  J Allergy Clin Immunol       Date:  2007-11       Impact factor: 10.793

7.  Efficient B cell responses to Borrelia hermsii infection depend on BAFF and BAFFR but not TACI.

Authors:  Gregory S Dickinson; Guizhi Sun; Richard J Bram; Kishore R Alugupalli
Journal:  Infect Immun       Date:  2013-11-11       Impact factor: 3.441

Review 8.  [Atacicept: a new B lymphocyte-targeted therapy for multiple sclerosis].

Authors:  H-P Hartung
Journal:  Nervenarzt       Date:  2009-12       Impact factor: 1.214

9.  Reduced BAFF-R and increased TACI expression in common variable immunodeficiency.

Authors:  Rita R Barbosa; Susana L Silva; Sara P Silva; Alcinda C Melo; M Conceição Pereira-Santos; João T Barata; Lennart Hammarström; Marília Cascalho; Ana E Sousa
Journal:  J Clin Immunol       Date:  2014-05-09       Impact factor: 8.317

10.  The murine equivalent of the A181E TACI mutation associated with common variable immunodeficiency severely impairs B-cell function.

Authors:  John J Lee; Ingrid Rauter; Lilit Garibyan; Esra Ozcan; Tatyana Sannikova; Stacey R Dillon; Anthony C Cruz; Richard M Siegel; Richard Bram; Haifa Jabara; Raif S Geha
Journal:  Blood       Date:  2009-07-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.